Fresenius Medical Care AG & Co. KGaA logo

Fresenius Medical Care AG & Co. KGaA (FMSC34)

Market Closed
7 Aug, 19:55
B3 B3
R$
123. 48
0
0%
R$
78.28B Market Cap
- P/E Ratio
9.66% Div Yield
4 Volume
- Eps
R$ 123.48
Previous Close
Add Transaction
Day Range
123.48 123.48
Year Range
105.05 137.1
Want to track FMSC34 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

FMSC34 closed Friday higher at R$123.48, an increase of 0% from Thursday's close, completing a monthly increase of 3.3133% or R$3.96. Over the past 12 months, FMSC34 stock lost -3.4709%.
FMSC34 is not paying dividends to its shareholders.
The last earnings report, released on May 04, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

FMSC34 Chart

People also search for

BioNTech SE
R$ 29.64
-0.202%
BeiGene Ltd. ADR
R$ 69
+6.679%
Biogen Inc. Depositary Receipt
R$ 172
0%
Dexcom Inc. - BDR
R$ 8.98
+4.0556%
Alnylam Pharmaceuticals Inc.
R$ 55.38
-0.4315%

Fresenius Medical Care AG & Co. KGaA (FMSC34) FAQ

What is the stock price today?

The current price is R$123.48.

On which exchange is it traded?

Fresenius Medical Care AG & Co. KGaA is listed on B3.

What is its stock symbol?

The ticker symbol is FMSC34.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 9.66%.

What is its market cap?

As of today, the market cap is 78.28B.

Has Fresenius Medical Care AG & Co. KGaA ever had a stock split?

No, there has never been a stock split.

Fresenius Medical Care AG & Co. KGaA Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Ms. Helen Giza CEO
B3 Exchange
- ISIN
Germany Country
113,079 Employees
21 May 2026 Last Dividend
- Last Split
- IPO Date

Overview

Fresenius Medical Care AG is a global leader in providing dialysis and related services to individuals suffering from renal diseases. The company operates across Germany, North America, and other international locations, delivering comprehensive care for patients with end-stage renal disease (ESRD) and acute kidney failure. Fresenius Medical Care AG engages in offering dialysis treatment, along with laboratory and diagnostic services, through its network of outpatient dialysis clinics. Additionally, it provides materials, training, and patient support services, including clinical monitoring and supply delivery. The company also extends its expertise to hospitals in the United States by offering dialysis services for hospitalized ESRD patients and those with acute kidney failure. Founded in 1996, Fresenius Medical Care AG has its headquarters in Bad Homburg, Germany, and maintains a reputation for developing, manufacturing, and distributing a wide range of healthcare products aimed at improving the quality of life for patients worldwide.

Products and Services

Fresenius Medical Care AG offers an extensive portfolio of products and services catering to the needs of renal disease patients and healthcare providers, including:

  • Dialysis Treatment and Related Services: The provision of dialysis treatment and associated laboratory and diagnostic services through outpatient clinics. Additionally, Fresenius offers support services such as clinical monitoring, follow-up assistance, and home delivery of supplies.
  • Hospital Dialysis Services: Contract-based dialysis services for hospitals in the U.S., targeting hospitalized patients with ESRD or acute kidney failure.
  • Healthcare Products: Development, manufacture, and distribution of healthcare products, including:
    • Polysulfone Dialyzers and Hemodialysis Machines for efficient dialysis treatment.
    • Peritoneal Dialysis Cyclers and Solutions designed for home dialysis treatment.
    • Hemodialysis Concentrates, Solutions, and Granulates to support dialysis processes.
    • Bloodlines, Renal Pharmaceuticals, and Systems for Water Treatment tailored for dialysis needs.
    • Acute Cardiopulmonary and Apheresis Products for critical care interventions.
  • Pharmaceuticals: Development, acquisition, and licensure of renal pharmaceuticals aimed at enhancing treatment outcomes for patients with renal diseases. Fresenius also supplies medications and renal care products directly to patients' homes or dialysis clinics.
  • Specialized Medical Services: Offering of vascular, cardiovascular, and endovascular specialty services, as well as vascular care ambulatory surgery center operations. Additionally, Fresenius provides physician nephrology and cardiology services, catering to a broad range of patient needs.

Fresenius Medical Care AG markets its products and services directly to dialysis clinics, hospitals, and specialized treatment centers through local sales forces, independent distributors, dealers, and sales agents, ensuring comprehensive coverage and accessibility for those in need.

Contact Information

Address: Else-KrOener-Strasse 1
Phone: 49 6172 609 0